Why the study?
Does timolol reduce blood pressure and alter hemodynamics compared to propranolol in hypertensive patients?
Does timolol reduce blood pressure and alter hemodynamics compared to propranolol in hypertensive patients?
Timolol is an effective antihypertensive agent with similar blood pressure and heart rate lowering effects to propranolol, but without a sustained reduction in cardiac output.
Answers are grounded in this paper and cite their sources.
Timolol matches propranolol for BP control without sustained cardiac output reduction; extends evidence on beta-blocker-specific hemodynamics in hypertension.
The antihypertensive activity of timolol, a new beta adrenergic blocking agent, was assessed in hypertensive patients. In hospitalized patients timolol, 5 mg orally every 8 hr for one week, resulted in a significant although mild reduction of blood pressure with diastolic pressure falling from a mean of 101 mm Hg to 91 mm Hg. Heart rate and cardiac output fell while total peripheral resistance increased. The Valsalva response, the reflex tachycardia following inhalation of amyl nitrite and the cardiovascular responses to infusion of isoproterenol were significantly inhibited. Timolol also was compared to propranolol in a randomized double-blind outpatient trial. The antihypertensive and bradycrotic effects of the two drugs were similar. Heart rate was reduced 18% by both drugs ( P < 0.05). Supine diastolic pressure fell 9% ( P < 0.05). Unlike the short term effects of timolol, and in contrast to propranolol, cardiac output did not remain reduced after five weeks of continuous treatment with timolol. It is concluded that timolol merits further investigation as an antihypertensive agent.
No takes yet. Share an insight, caveat, or question.
Franciosa et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: